Article
Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.
Pediatric nephrology (Berlin, Germany) - 1 Nov 2011
Kim Jon Jin, Goodship Tim H J, Tizard Jane, Inward Carol
Abstract excerpt
Atypical haemolytic uraemic syndrome (aHUS) is frequently associated with mutations in the gene encoding complement factor H (CFH). The clinical response to plasma therapy in aHUS is variable. We present here our experience of plasma therapy in three aHUS patients with CFH mutations. Three children presented aged 4, 22 and 6 months (patients 1-3 respectively) in acute kidney injury requiring dialysis. Plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.